While several COVID-19 vaccines have been approved to date, the constant evolution of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) receptor-binding domain (RBD) has challenged the...

In breakthrough research, scientists have identified synthetic mini-antibodies to combat Covid-19. The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and...